Physician profile
David W Mcdermott
NPI 1720166119
$6,415.73
in general payments reported to CMS, 2019-2025
41 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $55.23 · 2021: $299 · 2022: $322 · 2023: $661 · 2024: $3,051 · 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648 · Consulting Fee: $2,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,648.32 |
| Consulting Fee | $2,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,719.19 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $404.24 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $371.60 | 2024-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $264.87 | 2019-2025 | Provenge |
| Abbvie INC. | $235.32 | 2019-2025 | |
| Urogen Pharma, INC. | $229.94 | 2023-2025 | Jelmyto |
| Teleflex LLC | $163.46 | 2021-2025 | Urolift |
| Telix Pharmaceuticals | $160.49 | 2023-2025 | Illuccix |
| Allergan, INC. | $151.72 | 2019 | |
| Immunitybio, INC. | $126.07 | 2024-2025 | |
| Janssen Biotech, INC. | $122.63 | 2019-2024 | Erleada, Akeega |
| Pfizer INC. | $112.71 | 2019-2025 | |
| Boston Scientific Corporation | $100.84 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Lithovue |
| Axonics, INC. | $97.34 | 2024 | Axonics |
| Baxter Healthcare | $94.53 | 2024 | Tisseel |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $86.87 | 2020-2023 | Titan |
| Antares Pharma, INC. | $86.59 | 2019-2024 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $78.48 | 2019 | |
| Neotract INC. | $77.54 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $72.74 | 2021-2022 | |
| Genentech USA, INC. | $67.83 | 2022 | |
| Renovia INC | $66.78 | 2019 | |
| Urovant Sciences INC | $58.13 | 2021-2022 | |
| Tolmar, INC. | $54.69 | 2023-2024 | |
| Agiliti Surgical, INC. | $54.41 | 2023 | Sonablate |
| Endo Pharmaceuticals INC. | $45.84 | 2022-2023 | Aveed, Xiaflex |
| Tempus Ai, INC | $29.65 | 2024 | |
| Merck Sharp & Dohme LLC | $28.23 | 2025 | Keytruda Qlex, Keytruda |
| Endo USA, INC. | $27.77 | 2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $25.44 | 2021 | |
| Halozyme INC | $21.77 | 2023 | |
| Medtronic, INC. | $21.13 | 2022 | |
| Accord Healthcare, INC. | $21.10 | 2023 | |
| 180 Medical, INC. | $20.76 | 2021 | |
| Amgen INC. | $18.69 | 2020 | |
| Hollister Incorporated | $17.33 | 2023 | Vapro |
| Novartis Pharmaceuticals Corporation | $17.07 | 2025 | |
| Calyxo, INC. | $17.05 | 2025 | Cvac Aspiration System |
| Sagent Pharmaceuticals | $16.31 | 2023 | Glydo |
| Vertex Pharmaceuticals Incorporated | $15.76 | 2025 | |
| Therapeuticsmd, INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.